Early pregnancy protein multiplex screening reflects circulating and urinary divergences associated with the development of preeclampsia

References

• Osungbade KO, Ige OK. Public health perspectives of preeclampsia in developing countries: Implication for health system strengthening. J Pregnancy 2011;2011:481095.
   PubMedGoogle Scholar
• Wyse DG, Nath FC, Brownell AK. Benign X-linked (Emery-Dreifuss) muscular dystrophy is not benign. Pacing Clin Electrophysiol. 1987;10:533–37.
   PubMed Web of Science ®Google Scholar
• Xiao J, Niu J, Ye X, Yu Q, Gu Y. Combined biomarkers evaluation for diagnosing kidney injury in preeclampsia. Hypertens Pregnancy 2013;32:439–49.
   PubMed Web of Science ®Google Scholar
• Kolialexi A, Mavreli D, Tounta G, Mavrou A, Papantoniou N. Urine proteomic studies in preeclampsia. Proteomics Clin Appl. 2015;9:501–06.
   PubMed Web of Science ®Google Scholar
• Garza-Veloz I. Castruita-De la Rosa C, Cortes-Flores R, et al. No association between polymorphisms/haplotypes of the vascular endothelial growth factor gene and preeclampsia. BMC Pregnancy Childbirth. 2011;11:35.
   Google Scholar
• Martinez-Fierro ML, Garza-Veloz I, Carrillo-Sanchez K, Martinez-Gaytan V, Cortes-Flores R, Ochoa-Torres MA, et al. Expression levels of seven candidate genes in human peripheral blood mononuclear cells and their association with preeclampsia. Hypertens Pregnancy 2014;33:191–203.
   PubMed Web of Science ®Google Scholar
• Austdal M, Skrastad RB, Gundersen AS, Austgulen R, Iversen AC, Bathen TF. Metabolomic biomarkers in serum and urine in women with preeclampsia. PLoS One 2014;9:e91923.
   PubMed Web of Science ®Google Scholar
• Moran P, Lindheimer MD, Davison JM. The renal response to preeclampsia. Semin Nephrol. 2004;24:588–95.
   PubMed Web of Science ®Google Scholar
• Bernard A, Thielemans N, Lauwerys R, Van Lierde M. Selective increase in the urinary excretion of protein 1 (Clara cell protein) and other low molecular weight proteins during normal pregnancy. Scand J Clin Lab Invest. 1992;52:871–78.
   PubMed Web of Science ®Google Scholar
• Carty DM, Siwy J, Brennand JE, Zurbig P, Mullen W, Franke J, et al. Urinary proteomics for prediction of preeclampsia. Hypertension 2011;57:561–69.
   PubMed Web of Science ®Google Scholar
• Son GH, Kwon JY, Lee S, Park J, Kim YJ, Yun B, Park JH. Comparison of serum and urinary nephrin levels between normal pregnancies and severe preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2013;166:139–44.
   PubMed Web of Science ®Google Scholar
• Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, Kalluri R. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem. 2003;278:12605–08.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649–58.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33:8–15.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn. 2011;31:66–74.
   PubMed Web of Science ®Google Scholar
• Poon LC, Akolekar R, Lachmann R, Beta J, Nicolaides KH. Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks. Ultrasound Obstet Gynecol. 2010;35:662–70.
   PubMed Web of Science ®Google Scholar
• Martinez-Fierro ML, Garza-Veloz I, Castruita-Dela Rosa C, Ortiz-Castro Y, Aceves-Medina MC, Vazquez-Castro R, Delgado-Enciso I, Castaneda-Lopez ME. Plasma cancer biomarker multiplex screening and the risk of subsequent preeclampsia. Int J Cardiol. 2015;179:58–60.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, Blink AL, Sachs BP, Epstein FH, Sibai BM, et al. Urinary placental growth factor and risk of preeclampsia. JAMA 2005;293:77–85.
   PubMed Web of Science ®Google Scholar
• Leanos-Miranda A, Marquez-Acosta J, Cardenas-Mondragon GM, Chinolla-Arellano ZL, Rivera-Leanos R, Bermejo-Huerta S, Romero-Arauz JF, Alvarez-Jimenez G, Ramos-Leon JC, Ulloa-Aguirre A. Urinary prolactin as a reliable marker for preeclampsia, its severity, and the occurrence of adverse pregnancy outcomes. J Clin Endocrinol Metab. 2008;93:2492–99.
   PubMed Web of Science ®Google Scholar
• Leanos-Miranda A, Campos-Galicia I, Ramirez-Valenzuela KL, Chinolla-Arellano ZL, Isordia-Salas I. Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia. Hypertension 2013;61:1118–25.
   PubMed Web of Science ®Google Scholar
• Fliser D, Novak J, Thongboonkerd V, Argiles A, Jankowski V, Girolami MA, Jankowski J, Mischak H. Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol. 2007;18:1057–71.
   PubMed Web of Science ®Google Scholar
• Nolen BM, Orlichenko LS, Marrangoni A, Velikokhatnaya L, Prosser D, Grizzle WE, Ho K, Jenkins FJ, Bovbjerg DH, Lokshin AE. An extensive targeted proteomic analysis of disease-related protein biomarkers in urine from healthy donors. PLoS One 2013;8:e63368.
   PubMed Web of Science ®Google Scholar
• Brown MA, Lindheimer MD, De Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX–XIV.
   PubMed Web of Science ®Google Scholar
• Kosovic I, Prusac IK, Berkovic A, Marusic J, Mimica M, Tomas SZ. Expression of EGF, EGFR, and proliferation in placentas from pregnancies complicated with preeclampsia. Hypertens Pregnancy 2017;36:16–20.
   PubMed Web of Science ®Google Scholar
• Armant DR, Fritz R, Kilburn BA, Kim YM, Nien JK, Maihle NJ, Romero R, Leach RE. Reduced expression of the epidermal growth factor signaling system in preeclampsia. Placenta 2015;36:270–78.
   PubMed Web of Science ®Google Scholar
• Kauma SW, Bae-Jump V, Walsh SW. Hepatocyte growth factor stimulates trophoblast invasion: A potential mechanism for abnormal placentation in preeclampsia. J Clin Endocrinol Metab. 1999;84:4092–96.
   PubMed Web of Science ®Google Scholar
• Kappou D, Sifakis S, Konstantinidou A, Papantoniou N, Spandidos DA. Role of the angiopoietin/Tie system in pregnancy (Review). Exp Ther Med. 2015;9:1091–96.
   PubMed Web of Science ®Google Scholar
• Bateman A., Martin MJ, O'Donovan C, Magrane M, Apweiler R, Alpi E, Antunes R, Arganiska J, Bely B, Bingley M, et al. UniProt: A hub for protein information. Nucleic Acids Res. 2015;43:D204–212.
   PubMed Web of Science ®Google Scholar
• Nikuei P, Rajaei M, Malekzadeh K, Nejatizadeh A, Mohseni F, AtashAbParvar A. Accuracy of soluble endoglin for diagnosis of preeclampsia and its severity. Iran Biomed. J 2017;21:312–30.
   PubMedGoogle Scholar
• Bayram M, Taskaya A, Bagriacik EU, Ilhan MN, Yaman M. The effect of maternal serum sFAS/sFASL system on etiopathogenesis of preeclampsia and severe preeclampsia. J Matern Fetal Neonatal Med. 2012
   PubMedGoogle Scholar
• Radulescu C, Bacarea A, Hutanu A, Gabor R, Dobreanu M. Placental growth factor, soluble fms-Like tyrosine kinase 1, soluble endoglin, IL-6, and IL-16 as biomarkers in preeclampsia. Mediators Inflamm. 2016;2016:3027363.
   PubMed Web of Science ®Google Scholar
• Taraseviciene V, Grybauskiene R, Maciuleviciene R. sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics. Medicina (Kaunas) 2016;52:349–53.
   PubMed Web of Science ®Google Scholar
• Almasry SM, Elfayomy AK, Hashem HE. Ultrastructure and histomorphometric analysis of human umbilical cord vessels in preeclampsia: A potential role of VEGF, VEGFR-1 and VEGFR-2. Rom J Morphol Embryol. 2016;57:681–89.
   PubMed Web of Science ®Google Scholar
• Hohlagschwandtner M, Knofler M, Ploner M, Zeisler H, Joura EA, Husslein P. Basic fibroblast growth factor and hypertensive disorders in pregnancy. Hypertens Pregnancy 2002;21:235–41.
   PubMed Web of Science ®Google Scholar
• Tse C, Lefevre G, Berkane N, Flahault A, Toumi K, Brault D, Capeau J, Uzan S. Increased serum maternal levels of the HER2 oncoprotein p105 ectodomain in preeclampsia. Clin Chem Lab Med. 2004;42:142–46.
   PubMed Web of Science ®Google Scholar
• Liu J, Chakraborty C, Graham CH, Barbin YP, Dixon SJ, Lala PK. Noncatalytic domain of uPA stimulates human extravillous trophoblast migration by using phospholipase C, phosphatidylinositol 3-kinase and mitogen-activated protein kinase. Exp Cell Res. 2003;286:138–51.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Gao Y, Zhang L, Jia L, Wang P, Li H. Alterations of IL-6, IL-6R and gp130 in early and late onset severe preeclampsia. Hypertens Pregnancy 2013;32:270–80.
   PubMed Web of Science ®Google Scholar
• Garrido-Gomez T, Dominguez F, Quinonero A, Diaz-Gimeno P, Kapidzic M, Gormley M, Ona K, Padilla-Iserte P, McMaster M, Genbacev O, et al. Defective decidualization during and after severe preeclampsia reveals a possible maternal contribution to the etiology. Proc Natl Acad Sci USA 2017;114:E8468-E8477.
   PubMed Web of Science ®Google Scholar
• Khalil A, Maiz N, Garcia-Mandujano R, Elkhouli M, Nicolaides KH. Longitudinal changes in maternal soluble endoglin and angiopoietin-2 in women at risk for pre-eclampsia. Ultrasound Obstet Gynecol. 2014;44:402–10.
   PubMed Web of Science ®Google Scholar
• Karakus S, Bozoklu Akkar O, Yildiz C, Sancakdar E, Cetin M, Cetin A. Serum levels of ET-1, M30, and angiopoietins-1 and −2 in HELLP syndrome and preeclampsia compared to controls. Arch Gynecol Obstet.
   Web of Science ®Google Scholar
• Shim SS, Lee CH, Jun JK. Midtrimester maternal plasma concentrations of angiopoietin 1, angiopoietin 2, and placental growth factor in pregnant women who subsequently develop preeclampsia. Obstet Gynecol Sci. 2015;58:10–16.
   PubMedGoogle Scholar
• Kappou D, Sifakis S, Androutsopoulos V, Konstantinidou A, Spandidos DA, Papantoniou N. Placental mRNA expression of angiopoietins (Ang)-1, Ang-2 and their receptor Tie-2 is altered in pregnancies complicated by preeclampsia. Placenta 2014;35:718–23.
   PubMed Web of Science ®Google Scholar
• Ogge G, Romero R, Kusanovic JP, Chaiworapongsa T, Dong Z, Mittal P, Vaisbuch E, Mazaki-Tovi S, Gonzalez JM, Yeo L, et al. Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: The need for standardization in clinical practice. J Matern Fetal Neonatal Med. 2010;23:820–27.
   PubMed Web of Science ®Google Scholar
• Rodewald R, Karnovsky MJ. Porous substructure of the glomerular slit diaphragm in the rat and mouse. J Cell Biol. 1974;60:423–33.
   PubMed Web of Science ®Google Scholar
• Tojo A, Kinugasa S. Mechanisms of glomerular albumin filtration and tubular reabsorption. Int J Nephrol. 2012;2012:481520.
   PubMedGoogle Scholar
• Cooper LT, Jr., Hiatt WR, Creager MA, Regensteiner JG, Casscells W, Isner JM, Cooke JP, Hirsch AT. Proteinuria in a placebo-controlled study of basic fibroblast growth factor for intermittent claudication. Vasc Med. 2001;6:235–39.
   PubMed Web of Science ®Google Scholar
• Mazue G, Bertolero F, Garofano L, Brughera M, Carminati P. Experience with the preclinical assessment of basic fibroblast growth-factor (Bfgf). Toxicol Lett. 1992;64-5:329–38.
   Web of Science ®Google Scholar
• Zhong Y, Zhu F, Ding Y. Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: Systematic review and meta-analysis. BMC Pregnancy Childbirth 2015;15:191.
   PubMed Web of Science ®Google Scholar
• Aggarwal PK, Jain V, Sakhuja V, Karumanchi SA, Jha V. Low urinary placental growth factor is a marker of pre-eclampsia. Kidney Int. 2006;69:621–24.
   PubMed Web of Science ®Google Scholar
• Chaparro A, Gaedechens D, Ramirez V, Zuniga E, Kusanovic JP, Inostroza C, Varas-Godoy M, Silva K, Salomon C, Rice G, et al. Placental biomarkers and angiogenic factors in oral fluids of patients with preeclampsia. Prenat Diagn. 2016;36:476–82.
   PubMed Web of Science ®Google Scholar
• Ehrlich L, Hoeller A, Golic M, Herse F, Perschel FH, Henrich W, Dechend R, Huppertz B, Verlohren S. Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia. Hypertens Pregnancy 2017;36:175–85.
   PubMed Web of Science ®Google Scholar